Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in behçet's syndrome patients

International Immunology

Volumn 26, Issue 2, 2014, Pages 71-81

  Yüksel, Şahru ^a   Eren, Elif ^a   Hatemi, Gülen ^b   Sahillioǧlu, Ali Can ^a   Gültekin, Yetiş ^a   DemirÖz, Duygu ^a   Akdiş, Cezmi ^c   Fresko, Izzet ^b   ÖzÖren, Nesrin ^a  

^a BOGAZICI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

ASC; Autoinflammation; IL 1 ; NLR; TNF

Indexed keywords

ASC; AUTOINFLAMMATION; IL-1Β; NLR; TNF-Α;

ADULT; BEHCET SYNDROME; CARRIER PROTEINS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MUTATION; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; TURKEY; YOUNG ADULT;

EID: 84894102051     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt046     Document Type: Article

References (21)

1. Gül, A. 2005. Behçet's disease as an autoinflammatory disorder. Curr. Drug Targets Inflamm. Allergy 4:81.
2. Direskeneli, H. 2006. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 45:1461.
3. Mege, J. L., Dilsen, N., Sanguedolce, V. et al. 1993. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J. Rheumatol. 20:1544.
4. Düzgün, N., Ayaslioglu, E., Tutkak, H. and Aydintug, O. T. 2005. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease. Rheumatol. Int. 25:1.
5. Fernandes-Alnemri, T. and Alnemri, E. S. 2008. Assembly, purification, and assay of the activity of the ASC pyroptosome. Methods Enzymol. 442:251.
6. Martinon, F., Mayor, A. and Tschopp, J. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27:229.
7. International Study Group for Behçet's Disease. 1990. Criteria for diagnosis of Behçet's disease Lancet 5:1078.
8. Hatemi, G., Fresko, I., Tascilar, K. and Yazici, H. 2008. Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum. 58:1539.
9. Sayinalp, N., Ozcebe, O. I., Ozdemir, O., Haznedaroglu, I. C., Dündar, S. and Kirazli, S. 1996. Cytokines in Behçet's disease. J. Rheumatol. 23:321.
10. Memisoglu, H., Aksu, H. S. Z., Erken, E. and Göcük, M. 1991. Serum interleukin-1 level in Behçet's disease. In Oduffy, J. D. and KÖkmen, E., eds, Behçet's Disease, p. 387-391. Dekker, New York, NY.
11. Treudler, R., Orfanos, C. E. and Zouboulis, C. C. 1997. Increased serum levels of interleukin I-beta and basic fibroblast growth factor in severe Adamandiades-Behçet's disease.In Hamzaou, M., ed., Behçet's Disease, p. 33-37. Adhoua, Tunis.
12. Slobodin, G., Toukan, Y., Rosner, I. et al. 2007. LPS-stimulated production of TNF-alpha by peripheral blood monocytes in patients with Behcet's disease. Clin. Rheumatol. 26:764.
13. Tunc, R., Keyman, E., Melikoglu, M., Fresko, I. and Yazici, H. 2002. Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. J. Rheumatol. 29:2393.
14. Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N. and Tschopp, J. 2004. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20:319.
15. Koné-Paut, I., Sanchez, E., Le Quellec, A., Manna, R. and Touitou, I. 2007. Autoinflammatory gene mutations in Behçet's disease. Ann. Rheum. Dis. 66:832.
16. Hawkins, P. N., Lachmann, H. J., Aganna, E. and McDermott, M. F. 2004. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 50:607.
17. Aksentijevich, I., Putnam, C. D., Remmers, E. F. et al. 2007. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 56:1273.
18. Kirino, Y., Zhou, Q., Ishigatsubo, Y. et al. 2013. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc. Natl Acad. Sci. USA 110:8134.
19. Yu, J. W., Wu, J., Zhang, Z. et al. 2006. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ. 13:236.
20. Gül, A., Tugal-Tutkun, I., Dinarello, C. A. et al. 2012. Interleukin-1β- regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann. Rheum. Dis. 71:563.
21. Liang, L., Tan, X., Zhou, Q. et al. 2013. IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROSNLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease. Invest. Ophthalmol. Vis. Sci. 54:402.